- Molecular NameBifonazole
- Synonym(+-)-1-(p,alpha-Diphenylbenzyl)imidazole; (+-)1-([1,1'-Biphenyl]-4-ylphenylmethyl)-1H-imidazole; 1-((4-Biphenylyl)phenylmethyl)-1H-imidazole; 1-(alpha-(4-Biphenylyl)benzyl)imidazole; 1-(p,alpha-Diphenylbenzyl)imidazole; Bay h 4502; Bifonazol [inn-spanish]; Bifonazolum [inn-latin]; Trifonazole
- Weight310.4
- Drugbank_IDDB04794
- ACS_NO60628-96-8
- Show 3D model
- LogP (experiment)4.77
- LogP (predicted, AB/LogP v2.0)5.18
- pkaN/A
- LogD (pH=7, predicted)4.71
- Solubility (experiment)0.000348 mg/ml
- LogS (predicted, ACD/Labs)(ph=7)-4.08
- LogSw (predicted, AB/LogsW2.0)0.0
- Sw (mg/ml) (predicted, ACD/Labs)0.02
- No.of HBond Donors0
- No.of HBond Acceptors2
- No.of Rotatable Bonds4
- TPSA17.82
- StatusFDA approved
- Administrationtopic
- PharmacologyAn imidazole antifungal drug.
- Absorption_valueN/A
- Absorption (description)N/A
- Caco_2N/A
- BioavailabilityN/A
- Protein bindingN/A
- Volume of distribution (VD)N/A
- Blood/Plasma Partitioning ratio (D_blood)N/A
- MetabollsmN/A
- Half lifeN/A
- ExcretionN/A
- Urinary ExcretionN/A
- CleranceN/A
- ToxicityN/A
- LD50 (rat)N/A
- LD50 (mouse)N/A